<DOC>
	<DOCNO>NCT01851759</DOCNO>
	<brief_summary>Using placebo control , The purpose study evaluate efficacy safety methanesulfonic acid cinepazide injection relieve disable degree acute cerebral infarction patient , explore best safe effective dose well dose method .</brief_summary>
	<brief_title>Methanesulfonic Acid Cinepazide Injection Treatment Acute Cerebral Infarction</brief_title>
	<detailed_description>The study enroll 288 acute cerebral infarction patient . Patients assign randomly receive either Methanesulfonic acid cinepazide injection placebo treatment . All patient study receive standard care treatment clinical , diagnostic , laboratory , safety , follow-up evaluation . Follow-up evaluation , include National Institute Health stroke scale ( NIHSS ) , Barthel index score modified Rankin scale assessment , do periodically 90 day onset . The degree disable improved primary measure drug effectiveness .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>1 . Age 40 75 year old，male/ female； 2 . The clinical diagnosis first onset patient anterior circulation infarction suffer stroke history complete recover neurologic impairment ( mRS score ＜2 disease） 3 . Patients prove head skull CT cerebral hemorrhage excluded； 4. course disease≤72h，the NIHSS score ≥7 ≤22； 5 . Patients voluntarily sign write informed consent . 1 . Patients suffer cerebral infarction accompany disorder consciousness , posterior circulation infarction , lacunar infarction transient ischemic attack . 2 . Patients suffer brain arteritis , brain tumor , brain injury , intracranial infection , brain parasitic disease , . Patients suffer cardiac disease rheumatic heart disease , coronary heart disease atrial fibrillation . 3 . Patients suffer severe complication , expect survival period within three month . 4 . Patients require thrombolysis , anticoagulation , anti fibrosis treatment . 5 . Patients suffer serious brain artery stenosis go interventional therapy . 6 . Patients whose white blood cell neutrophils low limit normal reference value . 7 . Patients bleed tendency suffer serious bleed 3 month . 8 . Patients severe cardiac , liver kidney disease , whose kidney liver function test abnormal（ALT , AST≥1.5 time upper normal limit，Cr＞upper normal limit） . 9 . Patients complication malignant tumor , serious progressive disease blood , digestion system . 10 . Patients complication mental illness un want willing cooperate . 11 . Doubt alcohol , drug abuse history 12 . Allergic constitution allergic test drug ingredient . 13 . Pregnancy lactation woman recent fertility plan 14 . Patients participate clinical experiment three month test . 15 . The patient unsuitable participate clinical test view researcher</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>